Official Release of Achievements

The fully automatic production line for AVF needles by Manners Technology has obtained Grade A+ certification for medical‑device cleanliness issued by an internationally independent testing institute, supported by its full‑process particulate control and ultra‑clean sterility assurance system. By integrating Class‑100 cleanroom environments, online particulate purging after laser cutting, multi‑frequency sequential ultrasonic cleaning, and terminal ultrapure‑water rinsing with non‑distilled water alternatives, the system achieves industry‑leading standards: ≤ 3 residual particles (> 10 μm) per unit and bacterial endotoxin levels < 0.005 EU/mL. This breakthrough means the cleanliness of every AVF needle reaches the stringent levels required for cardiovascular and cerebrovascular implantable devices, laying a reliable cornerstone for infection prevention for immunocompromised dialysis patients.

R&D Background and Clinical Pain Points

For dialysis patients requiring 2–3 punctures per week, even trace‑level contamination may trigger severe long‑term cumulative consequences. Post‑manufacturing cleaning of conventional AVF needles faces profound challenges:

Laser‑cutting residues: While 5‑axis laser cutting delivers high precision, it generates submicron‑scale re‑solidified metal particles (dross) and oxide fumes that adhere strongly to inner cannula walls and complex side‑hole edges, resisting removal by conventional cleaning methods.

Hotbed for biofilm formation: Internal threads and dead spaces at the hub‑cannula junction are high‑risk zones for microbial and bacterial‑endotoxin growth. Once biofilms form, routine sterilisation cannot eradicate them.

Hidden risks of pyrogenic reactions: Even when sterile, residual endotoxins (pyrogens) entering the bloodstream may cause acute reactions such as fever, chills and hypotension, compromising dialysis tolerance.

Long‑term hazards of particulate embolism: Unremoved metallic or organic particulates entering the circulation may trigger microvascular embolism or chronic inflammation, exacerbating cardiovascular complications.

Core Technological Innovations

The manufacturer has built an in‑depth cleaning technology chain covering three phases: prevention, removal and monitoring.

Synchronous aerosol control and online purging during laser cutting: Local negative‑pressure dust extraction and supersonic inert‑gas shielding devices are integrated at the 5‑axis laser‑cutting station. The former extracts cutting fumes in real time; the latter blasts cutting zones to suppress dross formation. Immediately after cutting, needles enter a multi‑nozzle supercritical CO₂ purging station, leveraging its high diffusivity and low surface tension to penetrate micro‑holes and dislodge loose particles.

Sonochemistry‑enhanced multi‑frequency sequential ultrasonic cleaning: The cleaning line employs tri‑frequency ultrasonic waves (28 kHz, 68 kHz, 130 kHz) combined with sonochemical catalysts. Low‑frequency macro‑flow fields strip large particles, while medium‑ and high‑frequency cavitation effects penetrate micro‑holes. Sonochemical effects generate local high temperature and pressure at the moment cavitation bubbles collapse, breaking organic molecular bonds and effectively removing grease and biofilm precursors.

Terminal ultrapure‑water rinsing and drying with non‑distilled water: Replacing conventional distilled water, final rinsing uses ultrapure water (< 0.1 μS/cm) produced via continuous reverse osmosis, electrodeionisation and UV sterilisation. Subsequent drying occurs in a Class‑100 clean drying chamber using low‑dew‑point nitrogen purging and vacuum negative‑pressure drying, ensuring zero water residue inside cannulas and eliminating secondary contamination.

Mechanism of Action

Ultra‑rigorous cleaning processes function synergistically through physical, chemical and hydrodynamic mechanisms:

Supercritical CO₂ purging utilises the properties of supercritical‑state CO₂ - high gas‑like permeability and liquid‑like solvency - to extract particles embedded in microstructures, fully vaporising afterwards with no residue left.

Synergy of multi‑frequency ultrasound and sonochemistry: Ultrasonic waves of different frequencies generate cavitation bubbles of varying sizes for full‑range cleaning coverage. Local temperatures of approximately 5 000 K, pressures of 1 000 atmospheres, and induced hydroxyl radicals produced upon cavitation‑bubble collapse physically shatter and chemically decompose the most recalcitrant organic contaminants and biofilm matrices.

Ultra‑low‑endotoxin ultrapure water acts as a critical barrier. Conventional distilled water may become endotoxin‑contaminated during storage and transportation. On‑demand real‑time‑produced ultrapure water features extremely low endotoxin levels and high resistivity (indicating minimal ion content), preventing new crystal nuclei from forming due to inorganic‑salt residues.

Efficacy Validation

The cleaning system has passed rigorous third‑party testing in accordance with ISO 19227 (Cleanliness of Surgical Implants) and United States Pharmacopeia standards, alongside long‑term clinical follow‑up.

Laboratory extreme testing: Random scanning electron microscopy‑energy‑dispersive X‑ray spectroscopy inspection of inner cannula walls detected no typical processing contaminants such as silicon, aluminium or calcium. Laser particle counting of eluates from particulate‑elution tests yielded 100 % compliance with Grade A+ standards.

Endotoxin and sterility testing: High‑sensitivity kinetic turbidimetric limulus amebocyte lysate testing confirmed stable endotoxin levels below 0.005 EU/mL. Direct inoculation‑based 14‑day sterility culture achieved a Sterility Assurance Level (SAL) of 10⁻⁶.

Clinical adverse‑reaction monitoring: Monitoring of 5 000 consecutive dialysis sessions using this batch of AVF needles recorded zero cases of puncture‑related bacteraemia or pyrogenic reactions. The incidence of unexplained chills or hypotension in the early dialysis phase (within 30 minutes of blood priming) dropped from 1.2 % in historical controls to 0.1 %.

R&D Strategy and Philosophy

Manners Technology's quality strategy is to define cleanliness as a core performance parameter rather than an auxiliary attribute of products. It advocates the philosophy that micro‑level cleanliness determines macro‑level safety, holding that for blood‑invading devices, surface biophysical conditions are equally critical to functional parameters such as dimension and shape. Adopting strict standards derived from Good Manufacturing Practice (GMP) for pharmaceuticals to govern medical‑device cleaning workflows, the manufacturer has established standardised procedures for cleaning‑process validation and continuous monitoring. Its core principle lies in proactive risk control: prioritising cost‑intensive upstream prevention of contaminant generation and adhesion over reliance on aggressive end‑stage cleaning.

Future Outlook

Future cleaning and sterility assurance will advance toward molecular‑level in‑situ detection and self‑purifying materials. Manufacturers are developing miniature Raman spectroscopy online detection probes integrated into production lines. After cleaning and drying, the probes perform in‑situ scanning of inner cannula walls to identify and quantify residual organic‑contaminant molecules including proteins, nucleic acids and polysaccharides in real time, upgrading quality monitoring from "particle counting" to "molecular fingerprinting". Another revolutionary direction is photocatalytic self‑cleaning coatings: after electropolishing, nanoscale titanium‑dioxide photocatalytic coatings are deposited onto needle surfaces. Activated by UV irradiation during pre‑packaging sterilisation, these coatings decompose any trace residual organic matter. In the future, needles may maintain self‑cleaning activity under ambient light during storage. The manufacturer aims to set a new industry benchmark for "absolute cleanliness", embedding safety into every square micrometre of surface area.